Spruce Biosciences, Inc.
TA-ERT
MPS IIIB
Countdown
177days
FDA decision · ~ Dec 31, 2026 estimated
What's at stake
The FDA's approval decision on TA-ERT for MPS IIIB is due ~ Dec 31, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“The BLA submission for TA-ERT is anticipated in the fourth quarter of 2026.”